KYOWA KIRIN CO., LTD.;ST. MARIANNA UNIVERSITY SCHOOL OF MEDICINE
发明人:
YAMANO, YOSHIHISA
申请号：
CA3054778
公开号：
CA3054778A1
申请日:
2018.03.02
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The purpose of the present invention is to provide a novel therapeutic or preventive agent for human T-cell leukemia virus-1-associated myelopathy (HAM), characterized by containing an anti-human CC-chemokine receptor 4 (CCR4) antibody or a fragment of the antibody as an active ingredient and by a dosage regimen of said antibody or of a fragment of the antibody. The present invention pertains to a therapeutic or preventative agent for HAM, which is characterized by containing an anti-human CCR4 antibody or a fragment of the antibody as an active ingredient and in that the antibody or fragment of the antibody is administered at a low dose.
